ERN eUROGEN Webinar 139: Adrenal cancer and malignant cysts
This webinar was presented on the 28th of January by Prof. dr. Hans Langenhuijsen and Ass. Prof. Dr. Nikola Knežević. Prof. Langenhuijsen is a urologist, and professor in adrenal surgery at the Department of Urology, at Radboudumc in Nijmegen, The Netherlands. His research interests are: innovations in diagnostics, perioperative imaging and personalization of adrenal surgery. Ass. Prof. Knežević is also a urologist working at the Department of Urology at UHC Zagreb, in Croatia. During the first part of this webinar we offered an update on clinical presentation, staging, diagnostics, surgical techniques and prognosis of adrenal cancer. In part two the chance for malignancy in adrenal cysts was discussed and the eUROGEN explorative study for incidence of malignant cysts was explained in detail. Timestamps: 00:00 CPMS & contact information 00:23 Introduction by ERN eUROGEN Programme Manager 03:53 Presentation by Hans Langenhuijsen 20:43 Presentation by Nikola Knežević 46:49 Q&A Discussion Watch here the webinar by Prof. Hans Langenhuijsen on Adrenal incidentaloma - to biopsy or not ? • ERN eUROGEN Webinar 06: Adrenal incidental... eUROGEN is the European Reference Network for rare and complex urogenital diseases and conditions. Our multidisciplinary teams of experts are able to diagnose, suggest treatment or surgery, and then provide post-operative and transitional support. We have full members and affiliated partners across the majority of EU Member States. For more information or to contact us: Web: www.eurogen-ern.eu Email: [email protected] LinkedIn: / ern-eurogen Twitter/Instagram: @ERN_eUROGEN Facebook: / erneurogen YouTube: https://bit.ly/eUROGENyoutube Rare & Complex Urology book: https://shop.elsevier.com/books/rare-... ERN eUROGEN is a European Reference Network (ERN) approved by the ERN Board of Member States (BoMS). For more information about the ERNs and the EU health strategy, please see https://health.ec.europa.eu/european-... The ERNs are funded by the European Union. The views and opinions expressed in this webinar are those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor HaDEA can be held responsible for them.

ERN eUROGEN Webinar 140: Applicability of microRNA studies in testicular germ cell tumours

ERN eUROGEN Webinar 144: Long term continence issues in Hirschsprung disease

The Latest Guidelines for Transcranial Ultrasonic Monitoring

Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li

Ivermectin to Treat Cancer? Get the FACTS

Cancer and metabolism

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Doctor reveals undisclosed risks of COVID-19 vaccine

Revealed by 20 Years of Research in French Guiana and elsewhere | Antoine Adenis

Think Faster, Talk Smarter with Matt Abrahams

Dermatologist Explains: How To Spot Skin Cancer Early!

Artificial Stone Silicosis and its emerging epidemic

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

But what is quantum computing? (Grover's Algorithm)

The Devastating Effects Of Stage 4 Cancer

An Integrative, Pathology-Centered Perspective on Anal, Oral and Oropharyngeal HPV in Women

Krebs überleben: Ein Arzt und seine schlimmste Diagnose | SWR Doku

ERN eUROGEN Webinar 142: Lichen Sclerosus in Men

The Day I Lost My Son To Suicide | Can Ask Meh?

